From the Journals

Dance training ‘drastically’ reduces Parkinson’s progression, eases symptoms


 

‘Great potential’

Reached for comment, Demian Kogutek, PhD, director of music therapy, University of Evansville (Indiana), said that these preliminary findings from a longitudinal study are “promising.”

“I believe that dance therapy has a great potential for PD. The longitudinal aspect of this study undoubtedly adds to the current literature. Although it is a standardized assessment, it is somewhat subjective,” Dr. Kogutek said in an interview.

Going forward, Dr. Kogutek said he’d like to see other objective outcomes measured, such as objective assessments of balance, gait, hand strength, and dexterity.

Also weighing in on the results, Karen Lee, PhD, president and CEO of Parkinson Canada, said her organization is “encouraged by these preliminary findings as exercise and healthy activities are important for people with Parkinson’s. This study is part of a growing body of research that explores the link between the impact of activities and both motor and nonmotor symptoms of Parkinson’s.

“This research adds to growing evidence about the importance of exercise as part of the management of Parkinson’s, and we encourage people living with Parkinson’s to incorporate exercise as part of their approach to managing their health,” Dr. Lee said in an interview.

Funding for the project is provided in part by a National Science and Engineering Research Council Discovery Grant and by donations from the Irpinia Club of Toronto and others. Dr. Dr. DeSouza, Ms. Bearss, Dr. Kogutek, and Dr. Lee disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

COVID-19 vaccines are safe and effective for patients with migraine
MDedge Internal Medicine
Stroke risk in new-onset atrial fib goes up with greater alcohol intake
MDedge Internal Medicine
Novel NSAID–triptan drug effectively relieves migraine pain
MDedge Internal Medicine
FDA leader explains rationale leading to controversial Alzheimer’s drug approval
MDedge Internal Medicine
Guidance provided for telepsychiatry in tardive dyskinesia
MDedge Internal Medicine
Profound brain changes found in patients who died of COVID-19
MDedge Internal Medicine
FDA fast-tracks lecanemab for Alzheimer’s disease
MDedge Internal Medicine
Hearing loss tied to decline in physical functioning
MDedge Internal Medicine
Chronic stress and genetics can raise the risk of Alzheimer’s disease
MDedge Internal Medicine
FDA updates label for controversial Alzheimer’s drug aducanumab (Aduhelm)
MDedge Internal Medicine